A deteriorating health situation with a COVID pneumonia can quickly place you in the position of having to make a decision as to what level of medical intervention you want. If the prospect of needing active ventilation is likely, it is incredibly beneficial to have your care wishes documented well in advance. It could be that when these decisions need to be made by medical staff.
The existence of a legally-drafted advance directive and appointment of a legally-sanctioned person to represent you, could protect you from a prolonged and undignified death in an ICU. An AHD document, and an agent, can also ensure that, should you wish, scarce medical resources are freed up for those who want them (and who may be more likely to benefit from them). This makes the decision-making easier for the medical staff involved.
The Post-COVID Exit RPA Table
COVID-19 has affected the rating of a number of end of life options. (Yellow in the RPA chart below).
Specifically, chloroquine is now much less accessible. While Nembutal as an over-the-counter purchase is difficult, but this is compensated to some extent, by its continued availability over the Internet. While the availability of the R2D DeBreather had been interrupted during the worst months of COVID, this is has since improved. The Sarco project remains behind schedule. While the Swiss option is open to foreigners, it remains more difficult.
